Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical …
Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-intermediate S. aureus
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …
Systematic Review and Meta-Analysis of the Epidemiology of Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus …
S Zhang, X Sun, W Chang, Y Dai, X Ma - PloS one, 2015 - journals.plos.org
Background Vancomycin-intermediate Staphylococcus aureus (VISA) and heterogeneous
VISA (hVISA) are associated with vancomycin treatment failure, and are becoming an …
VISA (hVISA) are associated with vancomycin treatment failure, and are becoming an …
[HTML][HTML] Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections—a systematic review and meta-analysis
Objectives Vancomycin is currently the primary option treatment for methicillin-resistant
Staphylococcus aureus (MRSA). However, an increasing number of MRSA isolates with …
Staphylococcus aureus (MRSA). However, an increasing number of MRSA isolates with …
[HTML][HTML] Global distribution of heterogeneous vancomycin-intermediate Staphylococcus aureus strains (1997-2021): a systematic review and meta-analysis
M Keikha, M Karbalaei - Journal of Global Antimicrobial Resistance, 2024 - Elsevier
Abstract Background Heterogeneous vancomycin-intermediate Staphylococcus aureus is
considered as one of the main causes in treatment failure of vancomycin, which leads to …
considered as one of the main causes in treatment failure of vancomycin, which leads to …
恶性血液病患者医院感染状况及危险因素分析
王新有， 禹康， 郭新红 - 实用临床医药杂志, 2016 - jcmp.yzu.edu.cn
恶性血液病为一种起源于造血系统的疾病, 患者通常自身造血及免疫功能低下, 加之放,
化疗对骨髓造血及免疫功能的抑制, 机体防御机制和免疫系统遭到进一步破坏1 …
化疗对骨髓造血及免疫功能的抑制, 机体防御机制和免疫系统遭到进一步破坏1 …
Staphylococcus aureus: pathogenicity, antimicrobial resistance and clinical implications
AM Rossato, KC Reiter, PA d'Azevedo - Revista Prevenção de …, 2018 - revistas.ufpi.br
Objective: To conduct a reflection about the pathogenicity, antimicrobial resistance, and
clinical implications of the infections caused by Staphylococcus aureus. Method: Reflexive …
clinical implications of the infections caused by Staphylococcus aureus. Method: Reflexive …
[图书][B] A Genome Wide Approach to Identify Factors Asociated with Vancomycin Non-Susceptibility in Staphylococus aureus
JF Shurko - 2019 - search.proquest.com
Vancomycin (VAN) represents the standard of care in the treatment of Methicillin-Resistant
S. aureus (MRSA) infections and widespread use has driven antimicrobial resistance. While …
S. aureus (MRSA) infections and widespread use has driven antimicrobial resistance. While …
[PDF][PDF] MOLECULAR CHARACTERIZATION OF METHICILLIN-RESISTANT Staphylococcus aureus (MRSA) AND FACTORS ASSOCIATED WITH CLINICAL …
MP PHOKHAPHAN, S Kondo, A Apisarnthanarak… - 2017 - ethesisarchive.library.tu.ac.th
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common nosocomial
pathogens. Clinical outcomes by this pathogen ranges from skin and soft tissue infection …
pathogens. Clinical outcomes by this pathogen ranges from skin and soft tissue infection …
[PDF][PDF] methicillin-resistant Staphylococcus aureus
T Wongsuk, D Nutalai - core.ac.uk
Methicillin-resistant Staphylococcus aureus (MRSA) has been recognized as a major cause
of healthcare-associated and community-acquired infections. The resistant genes of MRSA …
of healthcare-associated and community-acquired infections. The resistant genes of MRSA …